{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:17:41Z","timestamp":1791253061872,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Pharmaceutical Education and Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.steroids.2015.05.010","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T12:08:29Z","timestamp":1433506109000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice"],"prefix":"10.1016","volume":"101","author":[{"given":"Syed Hamid","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaram Mohanrao","family":"Madhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira","family":"K.V.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5397-1829","authenticated-orcid":false,"given":"Eshvendar Reddy","family":"Kasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Narendra","family":"Bodduluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalandhar Reddy","family":"Mahareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Lahkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.steroids.2015.05.010_b0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jpsychires.2008.07.001","article-title":"Switching to duloxetine in selective serotonin reuptake inhibitor non-and partial-responders: effects on painful physical symptoms of depression","volume":"43","author":"Perahia","year":"2009","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.steroids.2015.05.010_b0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","article-title":"The burden of severe depression: a review of diagnostic challenges and treatment alternatives","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psc.2011.11.005","article-title":"The costs of depression","volume":"35","author":"Kessler","year":"2012","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.steroids.2015.05.010_b0020","series-title":"The global burden of disease: 2004 update","author":"Mathers","year":"2008"},{"key":"10.1016\/j.steroids.2015.05.010_b0025","series-title":"World Health Organization: Depression","year":"2012"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0030","doi-asserted-by":"crossref","first-page":"e4265","DOI":"10.1371\/journal.pone.0004265","article-title":"Stress and depression: preclinical research and clinical implications","volume":"4","author":"Bartolomucci","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.steroids.2015.05.010_b0035","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"Martinowich","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.steroids.2015.05.010_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.steroids.2015.01.021","article-title":"Effect of a novel 5-HT 3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice","volume":"96","author":"Gupta","year":"2015","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.steroids.2015.05.010_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S1516-44462004000300009","article-title":"The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression","volume":"26","author":"Juruena","year":"2004","journal-title":"Rev Bras Psiquiatr"},{"issue":"2","key":"10.1016\/j.steroids.2015.05.010_b0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.steroids.2015.05.010_b0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","article-title":"Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor","volume":"168","author":"Johnson","year":"2006","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ctcp.2013.10.001","article-title":"Effect of meditation on neurophysiological changes in stress mediated depression","volume":"20","author":"Kasala","year":"2014","journal-title":"Complement Ther Clin Pract"},{"issue":"5","key":"10.1016\/j.steroids.2015.05.010_b0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1383\/psyt.2006.5.5.166","article-title":"HPA axis function in mood disorders","volume":"5","author":"Watson","year":"2006","journal-title":"Psychiatry"},{"issue":"3","key":"10.1016\/j.steroids.2015.05.010_b0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2005.10.014","article-title":"Cortisol circadian rhythm alterations in psychotic major depression","volume":"60","author":"Keller","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.steroids.2015.05.010_b0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000012274","article-title":"Psychosomatic aspects of Cushing\u2019s disease","volume":"67","author":"Sonino","year":"1997","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(98)01010-5","article-title":"Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone","volume":"813","author":"Schaaf","year":"1998","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","article-title":"A mouse model of depression induced by repeated corticosterone injections","volume":"581","author":"Zhao","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.steroids.2015.05.010_b0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuint.2014.04.017","article-title":"Piperine reverses the effects of corticosterone on behavior and hippocampal BDNF expression in mice","volume":"74","author":"Mao","year":"2014","journal-title":"Neurochem Int"},{"issue":"11","key":"10.1016\/j.steroids.2015.05.010_b0095","first-page":"519","article-title":"Development of antidepressant drugs. Experience and prospects","volume":"32","author":"Bouvier","year":"2003","journal-title":"Presse Med (Paris, France: 1983)"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0048-4059(76)90077-1","article-title":"The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury","volume":"9","author":"Langcake","year":"1976","journal-title":"Physiol Plant Pathol"},{"issue":"2","key":"10.1016\/j.steroids.2015.05.010_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-9120(96)00155-5","article-title":"Resveratrol: a molecule whose time has come? And gone?","volume":"30","author":"Soleas","year":"1997","journal-title":"Clin Biochem"},{"issue":"Pt 5","key":"10.1016\/j.steroids.2015.05.010_b0110","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1042\/BST0351156","article-title":"Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications","volume":"35","author":"de la Lastra","year":"2007","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2010.03.043","article-title":"Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation","volume":"636","author":"Zhang","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): a review","volume":"92","author":"Wang","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-6632.2002.tb02918.x","article-title":"Cancer chemopreventive activity of resveratrol","volume":"957","author":"Bhat","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"2\u20133","key":"10.1016\/j.steroids.2015.05.010_b0130","first-page":"99","article-title":"Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant?","volume":"25","author":"Tredici","year":"1998","journal-title":"Drugs Exp Clin Res"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nyas.12145","article-title":"Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis","volume":"1290","author":"Mobasheri","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1677\/joe.1.06535","article-title":"Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats","volume":"189","author":"B\u00f6ttner","year":"2006","journal-title":"J Endocrinol"},{"issue":"6","key":"10.1016\/j.steroids.2015.05.010_b0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.euroneuro.2010.02.013","article-title":"Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system","volume":"20","author":"Xu","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.steroids.2015.05.010_b0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.phcgj.2013.08.004","article-title":"Honokiol reverses depressive-like behavior and decrease in brain BDNF levels induced by chronic corticosterone injections in mice","volume":"5","author":"Pitta","year":"2013","journal-title":"Pharmacognosy J"},{"issue":"2","key":"10.1016\/j.steroids.2015.05.010_b0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbr.2010.02.026","article-title":"Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain","volume":"210","author":"Mao","year":"2010","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.steroids.2015.05.010_b0160","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"3","key":"10.1016\/j.steroids.2015.05.010_b0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.steroids.2015.05.010_b0170","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.neubiorev.2008.04.006","article-title":"Corticosteroid\u2013serotonin interactions in the neurobiological mechanisms of stress-related disorders","volume":"32","author":"Lanfumey","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"10.1016\/j.steroids.2015.05.010_b0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.brainresbull.2009.03.009","article-title":"Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies","volume":"79","author":"Drzyzga","year":"2009","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.1016\/j.steroids.2015.05.010_b0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pnpbp.2008.11.016","article-title":"Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients","volume":"33","author":"Ba\u015fterzi","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbr.2011.11.016","article-title":"Peony glycosides reverse the effects of corticosterone on behavior and brain BDNF expression in rats","volume":"227","author":"Mao","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.steroids.2015.05.010_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2015.04.017","article-title":"The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis","author":"Pang","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.steroids.2015.05.010_b0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2014.01.039","article-title":"Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats","volume":"264","author":"Liu","year":"2014","journal-title":"Behav Brain Res"},{"issue":"11","key":"10.1016\/j.steroids.2015.05.010_b0200","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1021\/jf0112973","article-title":"Plant foods and herbal sources of resveratrol","volume":"50","author":"Burns","year":"2002","journal-title":"J Agric Food Chem"},{"issue":"2","key":"10.1016\/j.steroids.2015.05.010_b0205","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01048.2007","article-title":"Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin","volume":"294","author":"Lekli","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.steroids.2015.05.010_b0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/138161212798919075","article-title":"Resveratrol, a neuroprotective supplement for Alzheimer\u2019s disease","volume":"18","author":"Li","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.steroids.2015.05.010_b0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753425913488429","article-title":"Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson\u2019s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses","volume":"20","author":"Lofrumento","year":"2014","journal-title":"Innate Immun"},{"issue":"3","key":"10.1016\/j.steroids.2015.05.010_b0220","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/sj.bjc.6601568","article-title":"Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4\u2032-tetramethoxystilbene","volume":"90","author":"Sale","year":"2004","journal-title":"Br J Cancer"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X15001671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X15001671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T18:23:42Z","timestamp":1617647022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X15001671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":44,"alternative-id":["S0039128X15001671"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2015.05.010","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2015.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}